Safety and Tolerability of Moxonidine in the Treatment of Hypertension

By Schachter M.  

Drug Safety, Vol. 19, Iss. 3, 1998-09 ,pp. : 191-203

Adis International

Access to resources Recommend Favorite

Moxonidine and Ramipril in Patients with Hypertension and Obstructive Pulmonary Disease

By Feuring M.  

Clinical Drug Investigation, Vol. 20, Iss. 1, 2000-07 ,pp. : 19-24

Adis International

Access to resources Recommend Favorite

The Effect of Moxonidine on Endothelial Dysfunction in Metabolic Syndrome

By Topal Ergun  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 5, 2006-01 ,pp. : 343-348

Adis International

Access to resources Recommend Favorite

Identification, synthesis and pharmacological activity of moxonidine metabolites

By Wirth D.D.   He M.M.   Czeskis B.A.   Zimmerman K.M.   Roettig U.   Stenzel W.   Steinberg M.I.  

European Journal of Medicinal Chemistry, Vol. 37, Iss. 1, 2002-01 ,pp. : 23-34

Elsevier

Access to resources Recommend Favorite

Involvement of 2 -adrenoceptors in the cardiovascular effects of moxonidine

By Urban R.   Szabo B.   Starke K.  

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 19-28

Elsevier

Access to resources Recommend Favorite